(Q3)Sep 30, 2024 | (Q1)Mar 31, 2024 | (Q3)Sep 30, 2023 | |
---|---|---|---|
Operating Cash Flow (Indirect Method) | |||
Cash flow from continuing operating activities | -714.40%-7.85M | -934.68K | -963.43K |
Net income from continuing operations | -62.87%-9.55M | ---1.4M | ---5.86M |
Operating gains losses | ---- | --107.9K | ---- |
Depreciation and amortization | ---- | --185 | ---- |
Other non cash items | -13.42%1.67M | ---- | --1.93M |
Change In working capital | -333.88%-6.94M | --242.19K | --2.97M |
-Change in prepaid assets | -159.31%-70.58K | ---120.17K | --119K |
-Change in payables and accrued expense | -341.17%-6.87M | --362.36K | --2.85M |
Cash from discontinued investing activities | |||
Operating cash flow | -714.40%-7.85M | ---934.68K | ---963.43K |
Investing cash flow | |||
Cash flow from continuing investing activities | 83.37%-43.94M | -3.13K | -264.18M |
Net PPE purchase and sale | ---- | ---3.13K | ---- |
Net other investing changes | ---43.2M | ---- | ---- |
Cash from discontinued investing activities | |||
Investing cash flow | 83.37%-43.94M | ---3.13K | ---264.18M |
Financing cash flow | |||
Cash flow from continuing financing activities | -80.42%52.12M | 54.39K | 266.19M |
Net issuance payments of debt | 114.19%202K | ---23.82K | ---1.42M |
Net common stock issuance | -83.91%42.65M | ---6K | --265.05M |
Net other financing activities | ---- | --84.21K | ---- |
Cash from discontinued financing activities | |||
Financing cash flow | -80.42%52.12M | --54.39K | --266.19M |
Net cash flow | |||
Beginning cash position | --0 | --1.27M | --6K |
Current changes in cash | -67.96%337.26K | ---883.43K | --1.05M |
End cash Position | 65.73%1.59M | --388.4K | --957.66K |
Free cash flow | -768.39%-8.58M | ---937.81K | ---988.43K |
Currency Unit | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP |
No Data
No Data